-+ 0.00%
-+ 0.00%
-+ 0.00%

ORIC PHARMACEUTICALS - ENOZERTINIB WELL TOLERATED WITH NO GRADE 4/5 TRAES OR TREATMENT DISCONTINUATIONS

路透·10/23/2026 07:15:00

请登录查看新闻详情